2005
DOI: 10.1161/01.cir.0000151313.18547.a2
|View full text |Cite
|
Sign up to set email alerts
|

Functional Integration of Electrically Active Cardiac Derivatives From Genetically Engineered Human Embryonic Stem Cells With Quiescent Recipient Ventricular Cardiomyocytes

Abstract: We conclude that electrically active, hESC-derived CMs are capable of actively pacing quiescent, recipient, ventricular CMs in vitro and ventricular myocardium in vivo. Our results may lead to an alternative or a supplemental method for correcting defects in cardiac impulse generation, such as cell-based pacemakers.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

18
314
1
5

Year Published

2005
2005
2013
2013

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 433 publications
(339 citation statements)
references
References 35 publications
18
314
1
5
Order By: Relevance
“…While this manuscript was under review, two groups also reported the successful formation of stable graft of hESC-derived cardiomyocytes in pharmacologically immunosuppressed pigs 56 and guinea pigs. 57 Importantly, these independent studies by the Gepstein and Li groups unambiguously demonstrated electromechanical integration of the cardiac implants with the host myocardium, and they provide exciting proof-of-concept for this cell type for applications as a biological pacemaker. Their cell preparation differed from our own in that they physically dissected spontaneous beating foci from differentiated embryoid body outgrowths, an approach not readily scalable to human cell therapeutic applications.…”
Section: Discussionmentioning
confidence: 96%
“…While this manuscript was under review, two groups also reported the successful formation of stable graft of hESC-derived cardiomyocytes in pharmacologically immunosuppressed pigs 56 and guinea pigs. 57 Importantly, these independent studies by the Gepstein and Li groups unambiguously demonstrated electromechanical integration of the cardiac implants with the host myocardium, and they provide exciting proof-of-concept for this cell type for applications as a biological pacemaker. Their cell preparation differed from our own in that they physically dissected spontaneous beating foci from differentiated embryoid body outgrowths, an approach not readily scalable to human cell therapeutic applications.…”
Section: Discussionmentioning
confidence: 96%
“…Since ESCs have the potential to differentiate into cardiomyocytes, 34,35 transplantation of ESC-derived pacemaker cells induced spontaneous ectopic beats. 36,37 …”
Section: Gene and Cell Therapymentioning
confidence: 99%
“…Different methods have been used in an attempt to do so. A number of studies have used GFP-or CFP-expression to label the injected cells [78][79][80][81][82], but in only a few studies do ESC-derived cardiomyocytes (ESC-CM) appear to be structurally integrated [79,82]. Immunohistochemistry is another common tool used to distinguish between the host cells and engrafted ESC-CM.…”
Section: Mechanical and Electrical Engraftment Of Transplanted Cells mentioning
confidence: 99%
“…1f). In most cases, however, the connexin-43 staining is very blurred or absent between the islands of transplanted stem cells and the rest of the myocardium [55,80,81,83]. One can also try to discern electrical connectivity between the host and engrafted cells by using a dye transfer technique [84,85].…”
Section: Mechanical and Electrical Engraftment Of Transplanted Cells mentioning
confidence: 99%
See 1 more Smart Citation